🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to assess the safety and tolerability of REGN2477 ...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-08
Trial ID
NCT02943239
This study is researching experimental drugs called trevogrumab and garetos...
Status
Active Not Recruiting
Location
Pinnacle Research Group
Start Date
2024-03-13
Trial ID
NCT06299098
Primary Objective: Determine blood concentrations of two formulations of RE...
Status
Completed
Location
Multiple Locations
Start Date
2016-03
Trial ID
NCT02741739
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of REGN2477+...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-02-19
Trial ID
NCT03710941
Treatments Being Tested
This is a study to assess the safety and bioeffect of REGN1033 (SAR391786) ...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01910220
Treatments Being Tested
This is a study to assess the safety and tolerability of subcutaneously adm...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01720576
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, single ascending do...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01507402
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multicenter phase 2...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01963598
Treatments Being Tested